| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 02/24/2011 | WO2010115172A3 Antigenic peptide of hsv-2 and methods for using same |
| 02/24/2011 | WO2010095879A3 Sirna to be bound to transcripts of apoptosis-related genes, and compositions for treating cancer using same |
| 02/24/2011 | WO2010011404A3 Vectors for delivery of light-sensitive proteins and methods of use |
| 02/24/2011 | WO2008020318A3 Non-viral compositions and methods for transfecting gut cells in vivo |
| 02/24/2011 | US20110046360 ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR |
| 02/24/2011 | US20110046204 Human Zip1, Zinc and Citrate for Prostate Cancer Screening |
| 02/24/2011 | US20110046201 Methods and compositions for seamless cloning of nucleic acid molecules |
| 02/24/2011 | US20110046005 Method and nucleic acids for the analysis of colon cell proliferative disorders |
| 02/24/2011 | US20110045589 Methods Of Controlling Proliferation And Differentiation Of Stem And Progenitor Cells |
| 02/24/2011 | US20110045583 Infectivity-enhanced conditionally-replicative adenovirus and uses thereof |
| 02/24/2011 | US20110045061 Gene therapy for diabetic ischemic disease |
| 02/24/2011 | US20110045002 Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function |
| 02/24/2011 | US20110045001 Transfection results of non-viral gene delivery systems by influencing of the innate immune system |
| 02/24/2011 | US20110044956 Nell-1 enhanced bone mineralization |
| 02/24/2011 | US20110044955 Altering memory by affecting staufen |
| 02/24/2011 | US20110044947 Methods of treating cardiac disorders |
| 02/24/2011 | CA2771228A1 Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip |
| 02/23/2011 | EP2287339A1 Methods and kits to detect hereditary angioedema type III |
| 02/23/2011 | EP2287337A2 Identification of surface-associated Antigenes used for the diagnosis and therapy of tumours |
| 02/23/2011 | EP2287323A1 Widespread gene delivery to the retina using systemic administration of AAV vectors |
| 02/23/2011 | EP2287319A1 Medical preparations for the treatment of alpha-galactosidase a deficiency |
| 02/23/2011 | EP2287309A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 02/23/2011 | EP2287306A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287305A1 RNA interference mediated inhibition of gene expression using short interfering nucleic acid (siNA) |
| 02/23/2011 | EP2287301A2 Methods and compositions to inhibit P2X7 receptor expression |
| 02/23/2011 | EP2287191A2 Human igm antibodies with the capability of inducing remyelination, and diagnostic and therapeutic uses thereof particularly in the central nervous system |
| 02/23/2011 | EP2287186A1 Nucleic acid and corresponding protein entitled STEAP-1 useful in treatment and detection of cancer |
| 02/23/2011 | EP2287182A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2287181A2 Differential in tumour gene products and use of same |
| 02/23/2011 | EP2286841A1 Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use |
| 02/23/2011 | EP2285964A1 Phage lambda display constructs |
| 02/23/2011 | EP2285853A2 Micellic assemblies |
| 02/23/2011 | EP2285828A1 Polypeptides involved in the neuroregeneration-promoting properties of olfactory ensheathing glia |
| 02/23/2011 | EP1801209B1 Modified human hepatitis c virus genomic rna having autonomous replicative competence |
| 02/23/2011 | EP1135504B1 Human ubiquitin ligase e3 for the modulation of nf-kappa b |
| 02/23/2011 | EP0972024B1 A tumor suppressor designated ts10q23.3 |
| 02/23/2011 | CN1902312B Method of constructing transgenic dendritic cell |
| 02/23/2011 | CN1655802B Bioadhesive directed somatic cell therapy |
| 02/23/2011 | CN101981185A Double-stranded lipid-modified RNA having high RNA interference effect |
| 02/23/2011 | CN101980726A Methods and means for treating DNA repeat instability associated genetic disorders |
| 02/23/2011 | CN101980017A Anti-TNF antibodies, compositions, methods and uses |
| 02/23/2011 | CN101979595A Dual expression vector for immunostimulatory RNA and HBV target gene silence RNA, construction and application thereof |
| 02/23/2011 | CN101979594A Influenza virus hemagglutinin fusion peptide-containing targeted recombinant molecule gene, protein encoded thereby and application thereof |
| 02/23/2011 | CN101979581A S7 gene and coded recombinant protein of grass carp reovirus strain, and acquisition method and application thereof |
| 02/23/2011 | CN101979561A Nucleic acid molecule macrophage inflammatory protein (MIP) 3 alpha antibody to nuclear antigen (ANA) 6 and application thereof to preparation of immunosuppressive medicaments |
| 02/23/2011 | CN101979558A Small interfering RNA (siRNA) molecule of targeted hepatitis B virus (HBV) gene and application thereof |
| 02/23/2011 | CN101979557A SiRNA molecule and application thereof to antiviral medicaments |
| 02/23/2011 | CN101979556A Small interfering ribose nucleic acid (siRNA) targeting molecule and application thereof |
| 02/23/2011 | CN101979555A Small interference RNA molecule and application thereof |
| 02/23/2011 | CN101979554A siRNA molecule interfering HBV gene and application thereof |
| 02/23/2011 | CN101979553A siRNA molecule for interfering HBV gene and antiviral application thereof |
| 02/23/2011 | CN101979552A Structure of targeted hepatitis C virus (HCV)F gene and application of targeted HCVF gene |
| 02/23/2011 | CN101979549A Gene medicament taking voltage-gated proton channel Hv1 as targeted locus for treatment of breast cancer |
| 02/22/2011 | US7893248 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 02/22/2011 | US7893247 siRNA targeting spleen tyrosine kinase |
| 02/22/2011 | US7893246 Sirna capable of inhibiting the expression of an oncogene involved in cervical cancer |
| 02/22/2011 | US7893244 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 02/22/2011 | US7893243 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 02/22/2011 | US7893215 Agonist antibodies to IL-23 receptor |
| 02/22/2011 | US7893204 Attractin/mahogany-like polypeptides |
| 02/22/2011 | US7893036 In vivo production of small interfering RNAs that mediate gene silencing |
| 02/22/2011 | US7893033 Targeting proteins to deliver therapeutic or diagnostic reagents |
| 02/22/2011 | US7893022 Anti-angiogenic methods and compositions |
| 02/22/2011 | US7892834 Cellular signal-responsive gene transcriptional regulation system |
| 02/22/2011 | US7892829 Cardiac muscle regeneration using mesenchymal stem cells |
| 02/22/2011 | US7892828 Method of identifying a MHC class I restricted T cell response |
| 02/22/2011 | US7892822 Recombinant vector containing infectious, viral genome sequences greater than 100 kb, method for producing same and use for the mutagenesis of the viral sequences |
| 02/22/2011 | US7892793 Allele-specific RNA interference |
| 02/22/2011 | US7892773 Expression vector comprising nucleotide sequences coding homeobox transcriptional regulator gene for identifying modulators for treatment and prevention of cell proliferative disorders of urogenital system |
| 02/22/2011 | US7892533 Modified vaccinia virus ankara for the vaccination of neonates |
| 02/22/2011 | CA2435503C Flt4(vegfr-3) as a target for tumor imaging and anti-tumor therapy |
| 02/22/2011 | CA2423833C Viruses targeted to hypoxic cells and tissues |
| 02/22/2011 | CA2410193C Neuronal serine-threonine protein kinase |
| 02/22/2011 | CA2392685C Antisense antibacterial method and composition |
| 02/17/2011 | WO2011020118A1 Methods and compositions for treatment of tuberous sclerosis complex |
| 02/17/2011 | WO2011020047A1 Use of il-15 to increase thymic output and to treat lymphopenia |
| 02/17/2011 | WO2011020023A2 Lipid formulated compositions and methods for inhibiting expression of a gene from the ebola virus |
| 02/17/2011 | WO2011019815A2 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq) |
| 02/17/2011 | WO2011019793A2 Individualized therapy of single gene disorders with genetically modified adult stem cells |
| 02/17/2011 | WO2011019679A1 Ccr2 inhibitors for treating conditions of the eye |
| 02/17/2011 | WO2011019081A1 Light-receiving channel rhodopsin having improved expression efficiency |
| 02/17/2011 | WO2011019074A1 Nucleic acid that controls fibrosis of cells or organs |
| 02/17/2011 | WO2011019065A1 Tumor angiogenesis inhibitor |
| 02/17/2011 | WO2011018798A2 Morpholino-based antisense agent |
| 02/17/2011 | WO2011018672A1 Methods and substances for stimulating muscle regeneration |
| 02/17/2011 | WO2010129674A3 Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| 02/17/2011 | WO2010108177A3 A method and composition using a dual specificity protein tyrosine phosphatase as an antimalarial drug target |
| 02/17/2011 | US20110040082 Modifications of antimetabolite gemcitabine for incorporation in CpG oligonucleotides |
| 02/17/2011 | US20110039279 Methods and compositions for diagnosing breast cancer |
| 02/17/2011 | US20110038924 Osteoarthritis gene therapy |
| 02/17/2011 | US20110038896 Biodegradable immunomodulatory formulations and methods for use thereof |
| 02/17/2011 | US20110038836 Device and Method for Transfecting Cells for Therapeutic Use |
| 02/17/2011 | CA2771022A1 Photochemical internalization method |
| 02/17/2011 | CA2771021A1 Photosensitizing compositions |
| 02/17/2011 | CA2770104A1 Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq) |
| 02/17/2011 | CA2768965A1 Use of il-15 to increase thymic output and to treat lymphopenia |
| 02/16/2011 | EP2284268A2 Conserved HBV and HCV sequences useful for gene silencing |
| 02/16/2011 | EP2284266A2 Functional and hyperfunctional sirna |
| 02/16/2011 | EP2284264A1 Induction of exon skipping in eukaryotic cells |
| 02/16/2011 | EP2284210A1 Charge conversional ternary polyplex |